1. Market Research
  2. > Pharmaceutical
  3. > OTC Market Trends
  4. > Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016


DelveInsight’s Report, “Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016”, provides comprehensive insights about the marketed drugs, drug sales, Phase III pipeline drugs and their API Manufacturersacross the globe. A key objective of the Smoking Cessation Report is to understand the market and pipeline status of the drugs around the Smoking Cessation to explore the generic development opportunities, licensing opportunities and to gain competitive advantage on designing pipeline startegies. The DelveInsight’s Report provides the historical and forecasted sales of the drugs till 2018. The Report gives insights into patents providing the patent protection data and marketing exclusivity of all the drugs across the Smoking Cessation. While the leading brands, companies and chemicals are considered thoroughly, DelveInsight’s report also provides details on the Global API Manufacturers across the globe covering Drug Master Filings of US, Europe and API Manufacturers in Asia specifically China and India.

Please note:This report requires certain updates. We have all the information available but require 3 business days to complete the process and ensure it is as up-to-date as possible. Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

SCOPE:
- A snapshot of the global Market and Phase III therapeutics scenario for Smoking Cessation.
- A review of the marketed products under prescription for Smoking Cessation, regulatory information and marketing status.
- Coverage of global patent coverage and detailed commentaries on the US patent challenges.
- Graphical representation of investigational products for patent expiry and market exclusivities across the globe.
- Product profiles for marketed products for Smoking Cessation with complete description of mechanism of action, therapeutic class, target, route(s) of administration and chemical details.
- Coverage of API Manufacturers for Smoking Cessation drugs in the United States, Europe and Asian Regions with location details.
- Coverage of Regulatory filings in theUS, Europe, and Asia specifically India and China for Smoking Cessation drugs.
- Coverage of Route of Synthesis of Active Pharmaceutical Ingredient associated with Smoking Cessation drugs.
- Coverage of Smoking Cessation Phase III pipeline products featuring sections on product description, mechanism of action, Chemical details and research & development progress.
- Coverage of the United States Drug Master File (US DMF) available for Phase III Pipeline Drugs.
- Key discontinued Marketed products.
- Global Sales Figure to 2018.

Reasons to buy
- Evaluate the marketing status and exclusivity details of Smoking Cessation key products to exploit opportunities for generic drug development opportunities.
- Identify and understand important and diverse types of therapeutics under Phase III development for Smoking Cessation.
- Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details and exclusivity with respect to Smoking Cessation.
- API intelligence over marketed drugs forSmoking Cessationand gaining primary intelligence over active ingredients manufacturers across the globe.
- API intelligence over leading Phase III Pipeline drugs.
- Develop and designstrategies by identifying the API manufacturers for Phase III Pipeline products to enhance and expand business potential and scope.
- Understanding the scope of the Phase III Drugs with nil regulatory filings.
- Understanding the chemical route of synthesis of approved drugs for Smoking Cessation.
- Uncovering opportunities in the rapidly growing US market.

Table Of Contents

Smoking Cessation-Global API Manufacturers, Marketed and Phase III Drugs Landscape, 2016

Illustrative Table of contents
1. Indication Overview
2. Market Drugs Landscape
2.1 Marketed Drugs
2.2 Marketed Details of Drugs by Application Type
2.3 Marketed Details of Drugs (NDA) by Marketing Status
2.4 Marketed Details of Drugs by Patent Expiration Timeline
3. Global API Manufacturers Assessment
3.1 API Manufacturers by United States Drug Master File (US DMF) Status
3.2 API Manufacturers by US DMF Status (Drug Specific)
3.3 API Manufacturers in Europe by Country
3.4 API Manufacturers in India by State
3.5 API Manufacturers in China by Province
3.6 Marketed Details of Approved Drugs by Geography
4. Phase III Drugs Landscape
4.1 Active Pharmaceutical Ingredient (API) Manufacturers Assessment for Phase III Pipeline Drugs
4.2 API Manufacturers by US DMF Status (Drug Specific)
5. Drugs Market Data and Forecasted Sales Figure-2018
6. Marketed Drugs for Smoking Cessation
6.1 Drug Name
6.1.1 Drug Description
6.1.2 Global Active Pharmaceutical Manufacturers for Drug
6.1.3 Approval Status of Drug
6.1.4 Patent and Exclusivity Details for Drug
6.1.5 Company Profile and Financials
7. Phase III Drugs for Smoking Cessation
7.1 Drug Name
7.1.1 Drug Description
7.1.2 United States Drug Master File (DMF)
8. Discontinued Drugs for Smoking Cessation
9. Appendix
10. Methodology
11. Consulting Services
12. Contact Us
13. Disclaimer

List of Tables

- Smoking Cessation Therapeutic Market, US, Marketed Drugs by Application Type, 2016
- Smoking Cessation Therapeutic Market, US, Marketed Drugs by Marketing Status, 2016
- Smoking Cessation Therapeutic Market, US, (Year), 2016
- Smoking Cessation Marketed Drugs, API Manufacturers by US DMF Status, 2016
- Smoking Cessation Marketed Drugs, US DMF Status Drug Specific (Number), 2016
- Smoking Cessation Drugs, API Manufacturers, Europe by Country, 2016
- Smoking Cessation Drugs, API Manufacturers, India by State, 2016
- Smoking Cessation Drugs, API Manufacturers, China by Province, 2016
- Smoking Cessation Drugs, API Manufacturers by Geography 2016
- Smoking Cessation Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
- Smoking Cessation Therapeutic Market, Global Sales-2018 (in million USD)
- API Manufacturers for Drug, 2016
- Phase III Drugs for Smoking Cessation, 2016
- Discontinued Drugs for Smoking Cessation, 2016

List of Figures

- Smoking Cessation Therapeutic Market, US, Marketed Drugs by Application Type (%), 2016
- Smoking Cessation Therapeutic Market, US, Marketed Drugs by Marketing Status (%), 2016
- Smoking Cessation Therapeutic Market, US, (Year), 2016
- Smoking Cessation Marketed Drugs, API Manufacturers by US DMF Status (%), 2016
- Smoking Cessation Marketed Drugs, US DMF Status Drug Specific (Number), 2016
- Smoking Cessation Drugs, API Manufacturers, Europe by Country, 2016
- Smoking Cessation Drugs, API Manufacturers, India by State, 2016
- Smoking Cessation Drugs, API Manufacturers, China by Province, 2016
- Smoking Cessation Drugs, API Manufacturers by Geography 2016
- Smoking Cessation Phase III Pipeline Drugs, US DMF Status Drug Specific (Number), 2016
- Smoking Cessation Therapeutic Market, Global Sales 2018 (in million USD)
- Drug, Patent/Exclusivity Expiry (Year), 2016

View This Report »

Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 24 Million searchable statistics with tables, figures & datasets
  • More than 10,000 trusted sources
24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Purchase Reports From Reputable Market Research Publishers
Global and Chinese Smoking Cessation Drugs Industry, 2016 Market Research Report

Global and Chinese Smoking Cessation Drugs Industry, 2016 Market Research Report

  • $ 3000
  • Industry report
  • November 2016
  • by Prof Research

The ’Global and Chinese Smoking Cessation Drugs Industry, 2011-2021 Market Research Report’ is a professional and in-depth study on the current state of the global Smoking Cessation Drugs industry ...

2016 Varenicline (Tartrate) (CAS 375815-87-5) Global Market Report

2016 Varenicline (Tartrate) (CAS 375815-87-5) Global Market Report

  • $ 2800
  • Industry report
  • August 2016
  • by Prof Research

The 'Global and Chinese Varenicline (Tartrate) Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Varenicline (Tartrate) industry with a ...

2016 Varenicline Tartrate (CAS 375815-87-5) Global Market Report

2016 Varenicline Tartrate (CAS 375815-87-5) Global Market Report

  • $ 2800
  • Industry report
  • August 2016
  • by Prof Research

The 'Global and Chinese Varenicline Tartrate Industry, 2011-2021 Market Research Report' is a professional and in-depth study on the current state of the global Varenicline Tartrate industry with a focus ...


Download Unlimited Documents from Trusted Public Sources

Cardiovascular Disease Statistics in the US

  • October 2016
    6 pages
  • Cardiovascular ...  

    Salicylic Acid  

    Pain Relief  

  • United States  

    North America  

View report >

Smoking Statistics Industry in Malaysia

  • October 2016
    11 pages
  • Smoking Statist...  

    Smoking Cessati...  

  • Malaysia  

View report >

Pharmacies And Drug Stores Markets in Australia

  • September 2016
    8 pages
  • Pharmacies And ...  

    Healthcare  

    OTC  

  • Australia  

View report >

Pathology Statistics

4 months ago

Otc Industry In The Us

6 months ago

Related Market Segments :

Smoking Cessation
Cloud Computing

ref:plp2016

Reportlinker.com © Copyright 2016. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.